Skip to main content
Financial toxicity screen

Comprehensive Score for financial Toxicity - FACIT-COST

COST is a 12-item FACIT measure of financial toxicity over the past 7 days, with an 11-item total and one unscored summary item. This page is catalogue information. Lower totals indicate greater financial toxicity for clinician review, not a diagnosis.

Page updated

12 itemsFACIT COST v2Higher total is betterClinician reviewed

What is the COST?

The Comprehensive Score for financial Toxicity asks about money strain linked to illness and treatment. Lower totals indicate greater financial toxicity. Published grades run from Grade 0 (26 or more) to Grade 3 (0) for clinician consideration. They do not determine benefits, billing, or treatment choice.

Development and clinical use

de Souza and colleagues developed COST with FACIT. Lirena presents COST - FACIT Version 2, which adds the unscored FT12 summary item to the 11 scored items.

Catalogue status
Catalogue information
Mode
Patient self-report
Reference period
Past 7 days
Edition
FACIT-COST version 2
Typical use
Review financial strain related to treatment
Direction
Lower totals indicate greater toxicity
Source
FACIT
Clinical role
Screening support

A focused client experience

COST is completed as a focused self-report and stored for clinician review. This public page does not collect answers or return a score.

  • One question at a time with visible progress
  • Large keyboard-operable response choices
  • Previous, next, and answer-review steps
  • Clear confirmation that results go to the clinic
Client viewQuestion 4 of 12

The illustration shows layout only. It does not reproduce COST item wording.

PreviousNext question

Designed to make evidence easy to review

The downloadable synthetic example illustrates report layout using invented response patterns, without patient data or instrument questions.

  • Named instrument, version, and provenance
  • Item-level response pattern without source wording
  • Methodology, references, and clinical boundary
  • Responsible clinician review rather than automated conclusions
Download the four-page sample
LIRENASynthetic example
Comprehensive Score for financial Toxicity - FACIT-COST
ReviewContextSource

Clinician review required

Understand the measure and its scoring conventions

FT1 to FT11 are rated Not at all 0 to Very much 4, and FT2, FT3, FT4, FT5, FT8, FT9 and FT10 are reversed (4 minus the response). The total is the sum of the item scores x 11 / the count of FT1 to FT11 items answered, from 0 to 44, and higher totals mean better financial wellbeing. At least 6 of the 11 items must be answered; a total prorated from fewer than 11 is flagged. FT12 is a summary item recorded for review and not scored. Published grades: Grade 0 no financial toxicity (26 or more), Grade 1 mild (14 to 25), Grade 2 moderate (1 to 13) and Grade 3 severe (0). A prorated total with a fraction takes the grade of its whole-number part.

  1. FACIT COST measureFACIT. Comprehensive Score for financial Toxicity (COST).
  2. COST validationde Souza JA, Yap BJ, Wroblewski K, et al. Measuring financial toxicity as a clinically relevant patient-reported outcome: the validation of the COmprehensive Score for financial Toxicity (COST). Cancer. 2017;123(3):476-484.

What clinics ask before they evaluate the COST

These answers stay inside educational catalogue scope. They do not replace official manuals or clinician judgement.

Does a low COST total diagnose financial hardship as a disorder?

No. Lower totals indicate greater financial toxicity for clinician review. They are not a diagnosis.

Can I complete COST here?

No. This landing does not collect answers or return a score.

Does COST decide treatment affordability?

No. It records reported financial strain. Billing, benefits, and treatment decisions remain with the clinic and the person.

Is this a credit or means test?

No. It is a patient-reported measure for clinician review.

See who needs psychosocial attention, why, and whether they are improving.

More Oncology assessments